Plasma Fractionation Market Size, Share, Growth Analysis, By Product(Albumin, Immunoglobulins (Intravenous, Subcutaneous, Others)), By Application(Neurology, Hematology, Oncology, Immunology), By End Use(Hospitals & Clinics, Clinical Research, and Others), By Region - Industry Forecast 2024-2031

Global Plasma Fractionation Market size was valued at around USD 30.87 billion in 2022 and is expected to rise from USD 33.43 billion in 2023 to reach a value of USD 63.27 billion by 2031, at a CAGR of 8.3% over the forecast period (2024–2031).

One method used to extract specific amounts from a mixture is called fractionation. Additionally, the fluid component of blood is called plasma, and it can be separated to produce other plasma derivatives such immunoglobulins and albumin. These generated plasma products are used to treat a variety of blood plasma-related illnesses due to their therapeutic properties. For example, coagulation factor VIII, a plasma product, is used to treat and prevent haemophilia. It is often used during surgical operations to prevent excessive blood loss. Likewise, immunoglobulins are used to address immunological deficits, both primary and secondary. 

The main driver of the global plasma fractionation market's growth is the world's ageing population, which is more likely to be susceptible to rare diseases that call for the usage of plasma derivatives. Additionally, the market for plasma fractionation is growing due to the increased use of immunoglobulins and alpha-1-antitrypsin in many medical fields globally. Additionally, a significant element driving the market's expansion is the global spike in plasma collection facilities. The market for plasma fractionation is also growing because of the government's supportive initiatives to raise knowledge about the usage of goods generated from plasma. The market's expansion is, however, limited by the high cost of items derived from plasma.